BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8654602)

  • 1. Favourable prognosis of cystadeno- over adenocarcinoma of the pancreas after curative resection.
    Ridder GJ; Maschek H; Klempnauer J
    Eur J Surg Oncol; 1996 Jun; 22(3):232-6. PubMed ID: 8654602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of the body and tail of the pancreas: is curative resection justified?
    Dalton RR; Sarr MG; van Heerden JA; Colby TV
    Surgery; 1992 May; 111(5):489-94. PubMed ID: 1317976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
    Conlon KC; Klimstra DS; Brennan MF
    Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cystic pancreatic tumors].
    Schneider C; Reck T; Greskötter KR; Köckerling F; Gall FP
    Langenbecks Arch Chir; 1993; 378(5):281-7. PubMed ID: 8412436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
    Nitecki SS; Sarr MG; Colby TV; van Heerden JA
    Ann Surg; 1995 Jan; 221(1):59-66. PubMed ID: 7826162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in 1001 patients with carcinoma of the pancreas.
    Connolly MM; Dawson PJ; Michelassi F; Moossa AR; Lowenstein F
    Ann Surg; 1987 Sep; 206(3):366-73. PubMed ID: 2820322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cystic pancreatic tumors--differential diagnosis, surgical therapy. Prognosis of cystic pancreatic tumors].
    Köhler J
    Kongressbd Dtsch Ges Chir Kongr; 2002; 119():128-32. PubMed ID: 12704875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms?
    Sarr MG; Carpenter HA; Prabhakar LP; Orchard TF; Hughes S; van Heerden JA; DiMagno EP
    Ann Surg; 2000 Feb; 231(2):205-12. PubMed ID: 10674612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cystadenoma and cystadenocarcinoma.
    von Segesser L; Rohner A
    Br J Surg; 1984 Jun; 71(6):449-51. PubMed ID: 6722483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant tumors of the pancreas and periampullary area. Our experience].
    Stabilini L; Arnone GB; Brigli G; Bisio M; Bonomo A; Semino G; Vitale B
    Minerva Chir; 1995 Oct; 50(10):835-41. PubMed ID: 8684629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities and limitations of curative resections in cancers of the pancreas].
    Klempnauer J; Ridder GJ; Bektas H; Pichlmayr R
    J Chir (Paris); 1996 May; 133(3):117-22. PubMed ID: 8763572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
    Lüttges J; Vogel I; Menke M; Henne-Bruns D; Kremer B; Klöppel G
    Virchows Arch; 1998 Sep; 433(3):237-42. PubMed ID: 9769127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aggressive resectional approach to cystic neoplasms of the pancreas.
    Horvath KD; Chabot JA
    Am J Surg; 1999 Oct; 178(4):269-74. PubMed ID: 10587182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloid (mucinous noncystic) carcinoma of the pancreas.
    Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
    Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan.
    Mukaiya M; Hirata K; Satoh T; Kimura M; Yamashiro K; Ura H; Oikawa I; Denno R
    World J Surg; 1998 Mar; 22(3):248-52; discussion 252-3. PubMed ID: 9494416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal adenocarcinoma of the body and tail of the pancreas.
    Sperti C; Pasquali C; Pedrazzoli S
    J Am Coll Surg; 1997 Sep; 185(3):255-9. PubMed ID: 9291403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas.
    Christein JD; Kendrick ML; Iqbal CW; Nagorney DM; Farnell MB
    J Gastrointest Surg; 2005; 9(7):922-7. PubMed ID: 16137585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic neoplasms of the exocrine pancreas.
    Mosimann F; Ribaux C; Schnyder P
    HPB Surg; 1990 Jul; 2(3):165-73; discussion 173-5. PubMed ID: 2278913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.